Michael F. Cola is CEO & President at Aevi Genomic Medicine, Inc. (GNMX). They have made 6 open-market trades across 4 companies since 2014, most recently 2026-05-19.
CIK 0001188940
6 open-market purchases totalling $1.8M since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CERC | BUY | 2020-06-09 | 2020-06-11 | $2.50 | $250K | -6.2% | -10.2% | -6.6% |
| GNMX | BUY | 2019-12-05 | 2019-12-09 | $0.13 | $533K | -3.9% | +20.7% | +16233.3% |
| PHAT | BUY | 2019-10-29 | 2022-02-18 | $19.00 | $186K | -0.7% | -26.0% | -52.9% |
| GNMX | BUY | 2017-10-17 | 2017-10-18 | $1.26 | $300K | +21.6% | +9.7% | -6.7% |
| MDGN | BUY | 2015-10-06 | 2015-10-08 | $6.50 | $250K | N/A | N/A | N/A |
| MDGN | BUY | 2014-12-01 | 2014-12-02 | $4.10 | $250K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.